Profile data is unavailable for this security.
About the company
NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. The Company operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
- Revenue in USD (TTM)11.67m
- Net income in USD-2.88m
- Incorporated2009
- Employees19.00
- LocationNexgel Inc2150 Cabot Blvd West,, Suite BLANGHORNE 19047United StatesUSA
- Phone+1 (215) 702-8550
- Fax+1 (302) 636-5454
- Websitehttps://nexgel.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunshine Biopharma Inc | 37.32m | -5.99m | 5.74m | 52.00 | -- | 0.2204 | -- | 0.1538 | -2.03 | -2.03 | 10.74 | 5.31 | 1.21 | 2.09 | 10.12 | 717,764.30 | -19.47 | -68.65 | -23.80 | -89.02 | 33.01 | 32.79 | -16.06 | -81.12 | 2.09 | -209.95 | 0.00 | -- | 44.75 | 340.11 | -13.94 | -- | 370.33 | -- |
| cbdMD Inc | 19.19m | -4.38m | 7.36m | 42.00 | -- | 0.8655 | -- | 0.3835 | -3.92 | -3.92 | 4.77 | 0.8104 | 1.83 | 2.83 | 18.96 | -- | -19.44 | -48.27 | -44.42 | -54.99 | 62.37 | 63.95 | -10.63 | -85.60 | 1.20 | -- | 0.00 | -- | -1.50 | -14.45 | 43.21 | -- | -32.56 | -- |
| Tian'an Pharmaceutical Co Ltd | 10.65m | 3.14m | 8.00m | -- | 0.0445 | 0.0097 | 2.20 | 0.7511 | 0.2246 | 0.2246 | 0.7611 | 1.03 | -- | -- | -- | -- | -- | -- | -- | -- | 68.54 | -- | 29.51 | -- | 13.36 | 25.66 | 0.00 | -- | 50.51 | -- | 106.71 | -- | -- | -- |
| Gelteq Ltd | 117.10k | -4.70m | 8.51m | 7.00 | -- | 0.7618 | -- | 72.68 | -0.4977 | -0.4977 | 0.0124 | 1.04 | 0.0078 | -- | 0.5155 | 16,728.25 | -31.47 | -17.38 | -40.60 | -19.16 | -- | -- | -4,011.74 | -4,507.46 | -- | -3.52 | 0.2106 | -- | -- | -- | -87.40 | -- | -- | -- |
| Biofrontera Inc | 37.17m | -17.57m | 9.07m | 92.00 | -- | -- | -- | 0.2441 | -1.84 | -1.84 | 4.07 | -0.2216 | 2.19 | 2.44 | 9.45 | 403,967.40 | -103.57 | -48.03 | -339.69 | -77.55 | 64.41 | 48.93 | -47.28 | -60.99 | 0.8033 | -47.48 | 2.37 | -- | 9.54 | 7.35 | 11.78 | -- | -35.51 | -- |
| Cuprina Holdings (Cayman) Ltd | 24.03k | -2.24m | 9.22m | 14.00 | -- | 1.52 | -- | 383.54 | -0.1234 | -0.1234 | 0.0013 | 0.2835 | 0.0049 | 13.39 | 0.7976 | 1,716.66 | -44.56 | -- | -131.50 | -- | -69.27 | -- | -9,194.46 | -- | 3.58 | -306.25 | 0.0244 | -- | -52.05 | -- | -39.39 | -- | -- | -- |
| Integrated Biopharma Inc | 53.43m | 672.00k | 9.31m | 153.00 | 14.14 | 0.4543 | 9.40 | 0.1742 | 0.0212 | 0.0212 | 1.71 | 0.6597 | 2.07 | 4.45 | 12.77 | 349,183.00 | 2.60 | 9.98 | 3.28 | 13.68 | 9.75 | 10.74 | 1.26 | 4.58 | 1.92 | -- | 0.0072 | -- | 8.02 | 0.5933 | 482.30 | -30.67 | -0.8556 | -- |
| CV Sciences Inc | 14.37m | -1.48m | 9.37m | 47.00 | -- | 6.09 | -- | 0.6525 | -0.008 | -0.008 | 0.078 | 0.0084 | 1.87 | 1.67 | 34.74 | 305,659.60 | -19.21 | -44.92 | -66.32 | -105.32 | 47.04 | 42.89 | -10.29 | -49.08 | 0.2125 | -2.02 | 0.3829 | -- | -1.87 | -21.80 | -177.18 | -- | -56.43 | -- |
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 9.52m | 233.00 | 0.0651 | 0.001 | 2.47 | 0.1345 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| Bon Natural Life Ltd | 18.67m | -1.99m | 10.12m | 96.00 | 18.63 | 0.2316 | -- | 0.5418 | 0.088 | 0.088 | 6.74 | 7.08 | 0.2541 | 6.07 | 1.64 | 194,486.40 | -2.79 | 5.82 | -3.97 | 7.86 | 20.77 | 28.53 | -10.98 | 10.83 | 1.61 | -4.44 | 0.1735 | 0.00 | -21.70 | 0.4899 | -577.58 | -- | 18.20 | -- |
| Nexgel Inc | 11.67m | -2.88m | 10.59m | 19.00 | -- | 2.04 | -- | 0.9075 | -0.3796 | -0.3796 | 1.53 | 0.6369 | 1.05 | 3.79 | 13.46 | 613,947.40 | -25.14 | -39.08 | -36.83 | -49.79 | 38.30 | 19.60 | -23.91 | -105.40 | 1.08 | -51.36 | 0.1439 | -- | 112.47 | 64.69 | -3.93 | -- | -- | -- |
| Akari Therapeutics PLC (ADR) | 0.00 | -15.77m | 10.67m | 8.00 | -- | -- | -- | -- | -0.600 | -0.600 | 0.00 | -- | 0.00 | -- | -- | 0.00 | -65.57 | -112.46 | -136.47 | -257.78 | -- | -- | -- | -- | -- | -27.77 | 0.0854 | -- | -- | -- | -97.75 | -- | -- | -- |
| Cellectar Biosciences Inc | 0.00 | -18.85m | 13.95m | 11.00 | -- | 1.40 | -- | -- | -10.78 | -10.78 | 0.00 | 2.94 | 0.00 | -- | -- | 0.00 | -72.62 | -104.57 | -141.24 | -133.43 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -4.23 | -- | 33.54 | -- |
| Lexaria Bioscience Corp | 522.00k | -10.79m | 15.49m | 7.00 | -- | 2.82 | -- | 29.68 | -0.5743 | -0.5743 | 0.0272 | 0.221 | 0.0659 | -- | 2.97 | 74,571.43 | -136.35 | -102.60 | -145.39 | -105.78 | 100.00 | 87.95 | -2,069.41 | -1,579.38 | -- | -285.30 | 0.00 | -- | 52.05 | 17.53 | -105.37 | -- | 48.50 | -- |
Data as of Feb 13 2026. Currency figures normalised to Nexgel Inc's reporting currency: US Dollar USD
6.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2025 | 89.02k | 1.09% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 31 Dec 2025 | 85.40k | 1.05% |
| Geode Capital Management LLCas of 31 Dec 2025 | 67.04k | 0.82% |
| Renaissance Technologies LLCas of 31 Dec 2025 | 55.31k | 0.68% |
| G1 Execution Services LLCas of 30 Sep 2025 | 43.63k | 0.54% |
| Simon Quick Advisors LLCas of 31 Dec 2025 | 35.72k | 0.44% |
| Vanguard Fiduciary Trust Co.as of 31 Dec 2025 | 34.04k | 0.42% |
| Jane Street Capital LLCas of 31 Dec 2025 | 29.47k | 0.36% |
| Citadel Securities LLCas of 30 Sep 2025 | 27.45k | 0.34% |
| Flaharty Asset Management LLCas of 31 Dec 2025 | 24.00k | 0.30% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
